胃肠内镜超声引导下取样的技术要点:欧洲胃肠内镜学会(ESGE)技术指南——2017年3月
该指南由欧洲胃肠内镜学会(ESGE)制定,针对实体肿块和淋巴结的常规内镜超声引导下取样,推荐25G或22G针,细针抽吸(FNA)与细针活检(FNB)针同等推荐;当主要目的是获取核心组织标本时,建议使用19G FNA或FNB针或22G FNB针。指南还就抽吸、针芯使用、扇形扫查、现场细胞学评估、囊性病变取样及抗生素预防等给出推荐。
要点
- 常规实体肿块和淋巴结取样推荐25G或22G针,FNA与FNB针同等推荐(高质量证据,强推荐)。
- 以获取核心组织标本为主要目的时,建议使用19G FNA或FNB针或22G FNB针(低质量证据,弱推荐)。
- 无现场细胞学评估时,建议FNA针3至4次穿刺或FNB针2至3次穿刺(低质量证据,弱推荐)。
核心结论
- ESGE针对内镜超声引导下取样各技术环节给出推荐,涵盖针具选择、抽吸、针芯、扫查、现场细胞学评估、囊性病变取样、抗生素预防及组织学评估。
研究设计与样本
- 欧洲胃肠内镜学会(ESGE)制定的技术指南,基于证据质量与推荐强度分级。
诊断标准与关键数值
- 常规实体肿块和淋巴结取样:推荐25G或22G针(高质量证据,强推荐);FNA与FNB针同等推荐(高质量证据,强推荐)。
- 以获取核心组织标本为主要目的时:建议使用19G FNA或FNB针或22G FNB针(低质量证据,弱推荐)。
- 使用25G或22G FNA针行实体肿块和淋巴结取样时:推荐使用10 mL注射器抽吸(高质量证据,强推荐);其他类型针具:低质量证据,弱推荐。
- 建议在将针从目标病灶撤出前中和残余负压(中等质量证据,弱推荐)。
- 对FNA针行实体肿块和淋巴结取样:不推荐也不反对使用针芯(高质量证据,强推荐);对FNB针:建议使用针芯(低质量证据,弱推荐)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
For routine EUS-guided sampling of solid masses and lymph nodes (LNs) ESGE recommends 25G or 22G needles (high quality evidence, strong recommendation); fine needle aspiration (FNA) and fine needle biopsy (FNB) needles are equally recommended (high quality evidence, strong recommendation).When the primary aim of sampling is to obtain a core tissue specimen, ESGE suggests using 19G FNA or FNB needles or 22G FNB needles (low quality evidence, weak recommendation).ESGE recommends using 10-mL syringe suction for EUS-guided sampling of solid masses and LNs with 25G or 22G FNA needles (high quality evidence, strong recommendation) and other types of needles (low quality evidence, weak recommendation). ESGE suggests neutralizing residual negative pressure in the needle before withdrawing the needle from the target lesion (moderate quality evidence, weak recommendation).ESGE does not recommend for or against using the needle stylet for EUS-guided sampling of solid masses and LNs with FNA needles (high quality evidence, strong recommendation) and suggests using the needle stylet for EUS-guided sampling with FNB needles (low quality evidence, weak recommendation).ESGE suggests fanning the needle throughout the lesion when sampling solid masses and LNs (moderate quality evidence, weak recommendation).ESGE equally recommends EUS-guided sampling with or without on-site cytologic evaluation (moderate quality evidence, strong recommendation). When on-site cytologic evaluation is unavailable, ESGE suggests performance of three to four needle passes with an FNA needle or two to three passes with an FNB needle (low quality evidence, weak recommendation).For diagnostic sampling of pancreatic cystic lesions without a solid component, ESGE suggests emptying the cyst with a single pass of a 22G or 19G needle (low quality evidence, weak recommendation). For pancreatic cystic lesions with a solid component, ESGE suggests sampling of the solid component using the same technique as in the case of other solid lesions (low quality evidence, weak recommendation).ESGE does not recommend antibiotic prophylaxis for EUS-guided sampling of solid masses or LNs (low quality evidence, strong recommendation), and suggests antibiotic prophylaxis with fluoroquinolones or beta-lactam antibiotics for EUS-guided sampling of cystic lesions (low quality evidence, weak recommendation). ESGE suggests that evaluation of tissue obtained by EUS-guided sampling should include histologic preparations (e. g., cell blocks and/or formalin-fixed and paraffin-embedded tissue fragments) and should not be limited to smear cytology (low quality evidence, weak recommendation).
引用
- Polkowski M, Jenssen C, Kaye P, et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline - March 2017. Endoscopy. 2017. PMID: 28898917. doi:10.1055/s-0043-119219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。